RFG Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History

RFG Advisory's VRTX Position: Q2 2026 in Review

RFG Advisory increased its Vertex Pharmaceuticals (VRTX) stake by 19% in Q2 2026, buying an estimated $144K and bringing the position to 1,989 shares worth $988K. The position accounts for 0.02% of the portfolio, ranked #579.

RFG Advisory first reported a position in VRTX in Q2 2019 and has held it in 15 quarters since. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

• RFG Advisory held 1,989 shares of Vertex Pharmaceuticals worth $988K as of Q2 2026.
• RFG Advisory bought 324 Vertex Pharmaceuticals shares in Q2 2026, an estimated $144K.
• Vertex Pharmaceuticals made up 0.02% of RFG Advisory's portfolio in Q2 2026, its #579 holding.
• RFG Advisory first reported a position in Vertex Pharmaceuticals in Q2 2019 and has held it in 15 quarters since.
• 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on RFG Advisory's 13F filing for Q2 2026, filed 15 Jul 2026.